Status:

RECRUITING

Characterization of Acute Myocardial Damage With Spectral Computed Tomography. (CADAMI-SPECTRAL)

Lead Sponsor:

Salamanca University Hospital

Collaborating Sponsors:

Hospital Universitario Ramon y Cajal

Conditions:

Myocarditis; Acute or Subacute

Takotsubo Cardiomyopathy

Eligibility:

All Genders

18+ years

Brief Summary

Clinical management of patients with chest pain and elevation of biomarkers of myocardial injury require an accurate diagnosis. Until now, cardiac magnetic resonance imaging (cMRI) is the gold standar...

Eligibility Criteria

Inclusion

  • Age ≥ 18 year.
  • Hospital admission due to chest pain and acute myocardial injury.
  • Clinical indication for cardiac MRI (CMR) due to suspected acute myocardial infarction with coronary angiography showing no significant lesions (\<50%) (MINOCA), acute myocarditis, or stress-induced cardiomyopathy.
  • Signed informed consent.

Exclusion

  • Contraindications to undergo cardiac MRI and CT with administration of gadolinium and/or iodine-based contrast, respectively.
  • Pre-existing cardiomyopathy.
  • Pre-existing chronic ischemic heart disease.
  • Invasive coronary angiography showing coronary lesions ≥50%.

Key Trial Info

Start Date :

September 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2025

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT06506071

Start Date

September 1 2022

End Date

September 1 2025

Last Update

July 23 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Complejo Asistencial Universitario de Salamanca. Instituto de Investigación Biomédica de Salamanca

Salamanca, Spain, 37007

Characterization of Acute Myocardial Damage With Spectral Computed Tomography. (CADAMI-SPECTRAL) | DecenTrialz